Mobile Devices in Clinical Trials for Neurological Diseases: CDISC Standards Development

March 10, 2017

Pointe Hilton Tapatio Cliffs Resort | Phoenix, AZ

Overview and Objectives

The Coalition Against Major Diseases (CAMD), a consortium within the Critical Path Institute, is focused on accelerating the regulatory sciences required to advance innovative treatments for Alzheimer Disease and related neurodegenerative diseases with impaired cognition and function.

In collaboration with The Clinical Data Interchange Standards Consortium (CDISC), CAMD will sponsor a workshop to advance the understanding of the data standards required to integrate data across clinical drug trials using mobile device technologies.

The objectives of the meeting are:

• Review the existing standards that apply to mobile devices that could be implemented in clinical drug trials and longitudinal disease progression studies;
• Identify/prioritize existing gaps;
• Develop a plan to accelerate the creation/implementation of CDISC standards required for future registration studies that assess mobility, sleep and cognitive
  performance;

Notes and action items from the meeting

Meeting Agenda